Pubblicazioni

Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide

2022 - MINERVA UROLOGY AND NEPHROLOGY
Sciarra, A.; Gentilucci, A.; Cattarino, S.; Salsiccia, S.; Mariotti, G.

Radiotherapy in metastatic castration resistant prostate cancer patients with oligo-progression during abiraterone-enzalutamide treatment. A mono-institutional experience

2019 - RADIATION ONCOLOGY
Valeriani, M.; Marinelli, L.; MacRini, S.; Reverberi, C.; Aschelter, A. M.; De Sanctis, V.; Marchetti, P.; Tronnolone, L.; Osti, M. F.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma